- Home
- GT vs OGN Comparison
GT vs OGN Comparison
Compare GT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- OGN
- Stock Information
- Founded
- GT 1898
- OGN 1923
- Country
- GT United States
- OGN United States
- Employees
- GT N/A
- OGN N/A
- Industry
- GT Automotive Aftermarket
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- GT Consumer Discretionary
- OGN Health Care
- Exchange
- GT Nasdaq
- OGN Nasdaq
- Market Cap
- GT 2.4B
- OGN 2.7B
- IPO Year
- GT N/A
- OGN N/A
- Fundamental
- Price
- GT $7.41
- OGN $10.57
- Analyst Decision
- GT Buy
- OGN Buy
- Analyst Count
- GT 4
- OGN 3
- Target Price
- GT $12.13
- OGN $17.33
- AVG Volume (30 Days)
- GT 8.7M
- OGN 3.6M
- Earning Date
- GT 11-03-2025
- OGN 10-30-2025
- Dividend Yield
- GT N/A
- OGN 0.75%
- EPS Growth
- GT N/A
- OGN N/A
- EPS
- GT 1.47
- OGN 2.69
- Revenue
- GT $18,489,000,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- GT N/A
- OGN N/A
- Revenue Next Year
- GT $0.51
- OGN $0.79
- P/E Ratio
- GT $5.02
- OGN $3.95
- Revenue Growth
- GT N/A
- OGN N/A
- 52 Week Low
- GT $7.38
- OGN $8.01
- 52 Week High
- GT $12.03
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- GT 26.62
- OGN 54.85
- Support Level
- GT $7.41
- OGN $10.05
- Resistance Level
- GT $7.99
- OGN $11.29
- Average True Range (ATR)
- GT 0.22
- OGN 0.35
- MACD
- GT -0.03
- OGN 0.00
- Stochastic Oscillator
- GT 1.97
- OGN 44.76
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.